DSpace@İnönü

"Increase in C-peptide levels after resolution of hyperglycemia in patients with type 2 diabetes mellitus: Myths or facts?"

Basit öğe kaydını göster

dc.contributor.author Topaloğlu, Ömercan
dc.contributor.author Evren, Bahri
dc.contributor.author Yoloğlu, Saim
dc.contributor.author Şahin, Şelale
dc.contributor.author Şahin, İbrahim
dc.date.accessioned 2021-03-11T12:43:27Z
dc.date.available 2021-03-11T12:43:27Z
dc.date.issued 2020
dc.identifier.citation TOPALOĞLU Ö,EVREN B,YOLOĞLU S,ŞAHİN Ş,ŞAHİN İ (2020). Increase in C-peptide levels after resolution of hyperglycemia in patients with type 2 diabetes mellitus: Myths or facts?. Annals of Medical Research, 27(2), 648 - 656. Doi: 10.5455/annalsmedres.2019.11.712 en_US
dc.identifier.uri https://app.trdizin.gov.tr/makale/TXpZMU5EYzJOZz09/increase-in-c-peptide-levels-after-resolution-of-hyperglycemia-in-patients-with-type-2-diabetes-mellitus-myths-or-facts-
dc.identifier.uri http://hdl.handle.net/11616/19555
dc.description DOI: https://doi.org/10.5455/annalsmedres.2019.11.712 en_US
dc.description.abstract Abstract:Aim: Long term control of glucotoxicity was shown to increase the secretion of insulin and C-peptide (Cp). We aimed to investigate the change in Cp levels after short term glycemic control in patients with uncontrolled type 2 diabetes mellitus (DM). Material and Methods: Patients with type 2 DM with uncontrolled hyperglycemia were included. Basal fasting Cp levels were measured both at admission (Cp-admission) and after control of hyperglycemia prior to discharge (Cp-discharge). Cp-difference was calculated as (Cp-discharge)-(Cp-admission). The patients were divided as group 1 (positive Cp-difference) and group 2 (negative Cp-difference), and group A (Cp-difference ≥+0.5) and group B (Cp-difference ≤-0.5). Results: Of the patients (n=123), 61.8% had positive Cp-difference, and mean Cp-differences were 0.16 (±1.59), 0.96 (±1.03), and -1.11 (±1.51) in all patients, group1 and 2; respectively (p=0.001). Mean body weight, creatinine and Cp-discharge were higher in group 1(p=0.045, p=0.013, p=0.001; respectively). Mean age, body mass index(BMI), diabetes duration, hospitalization, proteinuria, fasting and postprandial glucose, glucose-discharge, HbA1c, lipids, TSH, free T4, Cp-admission were similar in group 1 and 2.Cpdifference was correlated positively with Cp-discharge(p=0.001), negatively with Cp-admission (p=0.001). There were no significant differences between subgroups (age, BMI, diabetes duration, use of secretagogue, diabetic ketaoacidosis history, HbA1c (<10 or ≥10%), hyperlipidemia, microvascular complication) regarding to Cp-difference. Positive predictors of positive Cp-difference were cardiovascular disease (p=0.004; Odds Ratio(OR)=3.006) and higher Cp-discharge(p=0.001; OR=6.420);positive predictors of Cpdifference ≥+0.5 were male, lower Cp-admission and higher Cp-discharge. Conclusion: Our results indicate that short-term glycemic control has little but significant positive effect on basal Cp. Having cardiovascular disease was positive predictor for positive Cp-difference. en_US
dc.language.iso tur en_US
dc.rights info:eu-repo/semantics/openAccess en_US
dc.title "Increase in C-peptide levels after resolution of hyperglycemia in patients with type 2 diabetes mellitus: Myths or facts?" en_US
dc.type article en_US
dc.relation.journal Annals of Medical Research en_US
dc.contributor.department İnönü Üniversitesi en_US


Bu öğenin dosyaları:

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster